Precision Syringe
Home
Ophthalmology
Aesthetics & Dermatology
Veterinary and Research
Blog
Team
About Us
Contact Us
Precision Syringe
Home
Ophthalmology
Aesthetics & Dermatology
Veterinary and Research
Blog
Team
About Us
Contact Us
More
  • Home
  • Ophthalmology
  • Aesthetics & Dermatology
  • Veterinary and Research
  • Blog
  • Team
  • About Us
  • Contact Us
  • Home
  • Ophthalmology
  • Aesthetics & Dermatology
  • Veterinary and Research
  • Blog
  • Team
  • About Us
  • Contact Us

Aesthetics and Dermatology

AESTHETICS AND DERMATOLOGY

Where one millimeter is the difference between a good outcome and a complication report

You already know this. You know the supratrochlear artery sits 3.34mm deep at the glabella, with a standard deviation of 0.6mm. You know the corrugator supercilii is only 2-3mm thick. You know that eyelid skin — the thinnest on the body — measures 0.3 to 0.5mm, with no subcutaneous fat beneath it.


What you may not have considered is what your syringe is doing while you work at those depths.

Aesthetic Injection

The clinical reality of one millimeter

Upper-face aesthetic injection has a 16% total complication rate (meta-analysis). That number isn’t about bad technique. It’s about anatomy that doesn’t forgive small errors — delivered through instruments that weren’t designed for the precision the anatomy demands.


  • At the glabella, the supratrochlear artery sits 3.34mm deep (SD 0.6mm). A 1-2mm depth error puts the needle tip intravascular. Sixty published cases of inadvertent vascular occlusion in this region show a 49% rate of permanent vision loss.
  • At the corrugator, the muscle is 2-3mm thick. Inject 1-2mm too deep and toxin reaches the levator palpebrae. The result is eyelid ptosis — a 0.71% incidence rate that, across roughly 7 million annual US treatments, means approximately 50,000 cases per year.
  • At the crow’s feet, the lateral rectus muscle sits 15mm from the injection zone. That sounds like margin. But toxin diffuses 10-15mm from the injection point, and a 2mm placement error compounds across that entire diffusion zone. The consequence is diplopia.
  • At the tear trough, the skin is 0.5mm thick. Place filler 1.5mm too superficial and you get the Tyndall effect — a bluish discoloration visible through translucent skin that may require hyaluronidase to resolve.


These aren’t rare anatomy. This is every patient, every treatment day.

Why one millimeter matters here

A standard thumb-plunger syringe asks you to push forward on the plunger while holding the barrel steady. The biomechanics work against you: the force vector that moves the plunger also moves the needle. Every injection involves some amount of unintended forward-and-back needle movement at the tip.


In anatomy where 1-2mm separates a correct plane from a complication, that movement matters.

The Precision Syringe

The Precision Syringe replaces the thumb-plunger mechanism with a finger-pull trigger. The force that delivers product is directed rearward — away from the needle tip, not toward it.

In a peer-reviewed study (DeLuna et al., Clinical Ophthalmology, 2019), the Precision Syringe demonstrated:

• 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04)

• 0.97mm reduction in forward-retraction needle movement

That fraction of a millimeter is the same order of magnitude as the clinical margins described above. We have not studied whether this improvement in needle stability changes complication rates. What the data show is that the instrument moves less while you work.

MOHS Micrographic Surgery

The clinical reality of one millimeter

MOHS depends on precise tissue architecture. The entire method — excise, map, section, read margins, re-excise — assumes that what the surgeon removes corresponds accurately to what the pathologist sees on the slide.

Local anesthetic injection is the first thing that happens to the tissue. If injection technique distorts the tissue plane, every downstream step inherits that distortion.

Tissue distortion corrupts margin assessment.Imprecise injection — too much volume in too small a space, or delivery at the wrong depth — swells and deforms the tissue before the first cut. The surgeon maps a margin on distorted anatomy. The pathologist reads a specimen that shrank approximately 20% at excision. A margin that reads “clear by 1mm” on the slide may be positive in vivo.

Eyelid MOHS is unforgiving. Eyelid skin is 0.3-0.5mm thick with no subcutaneous fat. There is almost no buffer between the injection plane and the structures beneath. Precise depth control during anesthetic delivery isn’t a preference — it’s a requirement of the anatomy.

The facial danger zones are measured in millimeters.The facial artery at the nasal ala averages 3.13mm deep but can sit as superficial as approximately 1mm, with a lumen of 1.32mm. In the temporal danger zone, MOHS cases carry a 4.5% rate of temporal nerve palsy. Forty percent of those cases don’t resolve.

The workforce gap is real. Seventy-four percent of dermatology residents plan to offer cosmetic injection services. Only 36% feel adequately trained. The syringe they learn on will shape the habits they carry into independent practice.

Why one millimeter matters here

MOHS surgeons inject local anesthetic dozens of times per day, often in the most anatomically complex regions of the face. The injection isn’t the procedure — it’s the setup for the procedure. But a syringe that introduces even small amounts of unintended needle movement can distort tissue, complicate margin reads, and put neurovascular structures at risk.

Standard thumb-plunger syringes direct force toward the needle tip. In periorbital skin that’s a third of a millimeter thick, or next to an artery that may be 1mm from the surface, that biomechanical reality deserves scrutiny.

The Precision Syringe

The same peer-reviewed data apply here. DeLuna et al. (Clinical Ophthalmology, 2019 — senior author Dr. Donny Suh, Precision Syringe CMO) measured:

• 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04)

• 0.97mm reduction in forward-retraction needle movement

For MOHS, this means less unintended needle movement during anesthetic delivery — in tissue where distortion directly affects margin accuracy and where neurovascular anatomy leaves no room for instrument-induced error.

Built for How You Practice

The Precision Syringe is compatible with standard Luer-lock needles and accepts the same cartridges and syringes you already use. It doesn’t require a new workflow — it changes the biomechanics of the one you have.

  • For aesthetic injectors: One-handed operation. The trigger mechanism frees the non-dominant hand for skin stabilization, landmarking, or aspiration. The rearward force vector means you can focus on depth and placement without compensating for plunger-induced movement.
  • For MOHS surgeons: Consistent, controlled anesthetic delivery across long case days. Less tissue distortion at the injection site. The same instrument works for field blocks, local infiltration, and periorbital cases.
  • For residents and fellows: A syringe that teaches precision from the start. The finger-pull trigger naturally separates the “hold steady” task from the “deliver product” task — a distinction that matters most when you’re still building the muscle memory.

Clinical Evidence

DeLuna D, Netzel A, Dietze J, Begley BA, Ndulue JK, Suh DW. “A comparison in precision and accuracy of the conventional syringe to the Suh precision syringe.” Clinical Ophthalmology, 2019;13:1833–1839.

  • Peer-reviewed, published study
  • 20.9% improvement in needle stability (p=0.04)
  • 0.97mm reduction in forward-retraction needle movement
  • Compared to standard thumb-plunger syringe

The study measured needle stability — not clinical outcomes. We cite the published anatomical literature above to illustrate why needle stability matters in these specialties. We have not conducted studies on complication rates.

Contact Us

Request a Sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Precision Syringe

© 2026 Precision Syringe, Inc. All rights reserved.    

Patents through 2040+ | 510(k) filed February 2026 DeLuna D, Suh DW, et al. “Comparison of modified syringe versus standard syringe use in a simulated intravitreal injection model.” Clinical Ophthalmology, 2019.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept